Company Overview

Company name: Helius Therapeutics
Description: Operator of a medicinal cannabis-based research and development company. The company’s operations include cannabinoid growing systems, advanced cannabinoid research laboratories and R&D operations, enabling consumers to avail quality cannabis therapeutics.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.helius.co.nz
Employees:
City: Auckland
State:
Country: New Zealand
Region: Oceania

Financial Highlights

Start up capital raised (USD Million): 28.13
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised NZD 20 million of angel funding from undisclosed investors on February 7, 2020, putting the company’s pre-money valuation at NZD 85 million. The funds will be used to expand operations and conduct the first clinical trials in New Zealand with kiwi patients.
Number of active investors:
Profile last updated: 11-Feb-2020
Last known valuation:
Last known valuation date: 07-Feb-2020